BioSpace News Archive

According to our new research study on “Pharmaceutical Fill and Finish Outsourcing Market Forecast to 2028 - COVID-19 Impact and Global Analysis By State of Finished Products

Sirnaomics Ltd. (the “Company"; together with its subsidiaries, the “Group” or “Sirnaomics"; stock code: 2257), a leading biopharmaceutical company engaging in discovery and development of advanced RNAi therapeutics, today announced it has dosed the first participant in a Phase I clinical trial of STP122G for anticoagulation treatment.

Scilex Holding Company, a majority-owned subsidiary of Sorrento Therapeutics, Inc. is providing certain preliminary unaudited financial results for the month ended May 31, 2023, and year-to-date as of May 31, 2023, based on currently available information.

Fluid Biomed Inc., a medical device company developing ReSolv™, the world’s first hybrid polymer-metal flow-diverting stent to treat brain aneurysms, announces the international launch of REDIRECT, its first-in-human clinical trial.

Aethlon Medical, Inc. announced that Guy Cipriani, Senior Vice President and Chief Business Officer, and James Frakes, Chief Financial Officer, will present a company overview at the 13th Annual LD Micro Invitational on Wednesday, June 7, 2023, at 1:30 PM PT.

Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and clinicians, today announced plans to present at the Goldman Sachs 44th Annual Global Healthcare Conference in Dana Point, CA.

LYNPARZA ® (olaparib) plus abiraterone approved in the US for the treatment of BRCA -mutated metastatic castration-resistant prostate cancer.

Lifecore Biomedical, Inc., a fully integrated contract development and manufacturing organization, reported results for the fiscal 2023 third quarter ended February 26, 2023.

Anavex Life Sciences Corp. announced today it was awarded new U.S. Patent No. 11,661,405.

Ocular Therapeutix, Inc. announced that Antony Mattessich, President and Chief Executive Officer of Ocular Therapeutix, will participate in a fireside chat at the Jefferies Global Healthcare Conference on Thursday, June 8, 2023 at 12:30 PM EDT at the Marriott Marquis in New York, NY.